… , Senior Vice President, Investor Relations. Please go ahead … , commercial execution and investment in our supply chain … leadership in PFA by investing in innovation, clinical … Session Follow Boston Scientific Corp (NYSE:BSX) Follow Boston Scientific Corp ( …

… . “We continue to invest significantly in the current … of atrial fibrillation. Boston Scientific began investing in Farapulse in 2014 … company noted during an investor event last year. “It … importantly, we made significant investments in the supply chain …

… ,” CEO Mike Mahoney told investors on an earnings call. … “Importantly, we made significant investments in the supply chain two … , followed soon after by Boston Scientific. The space is attracting … supply than last year. Boston Scientific also plans to expand …

… approval for a PFA system. Boston Scientific followed shortly after that, launching … a market filled with investment opportunities. Savvy investors who know where to … Investing News Network (INN) and approved by Cardiexin order to help investors …

… and CEO. Outlook: Boston Scientific forecasts net sales growth for …  8%-9%, respectively. Boston Scientific sees 2024 adjusted EPS … Read Next: FDA Classifies Boston Scientific’s Recall For Device … Benzinga does not provide investment advice. All rights reserved …

… 39;s Next for Boston Scientific? While Boston Scientific has outperformed the market … that can help investors address this is the … in earnings estimate revisions. Investors can track such revisions … the current fiscal year. Investors should be mindful of …

… the consensus forecast. Shares of Boston Scientific ticked up nearly 7% to … . Farapulse, Cardiovascular drive growth for Boston Scientific The company’s Cardiovascular segment … Mike Mahoney, Boston Scientific chair and CEO. “We continue to invest for the …

… per cent before the bell. Investor expectations around the performance of … procedures deferred during the pandemic. Boston Scientific, which generates most of its … to remain elevated through 2024. Boston Scientific now expects 2024 adjusted earnings …

… officer, Boston Scientific. "We continue to invest for the … net charges (credits), investment portfolio net losses (gains …   Media Relations     Investor Relations   Boston Scientific Corporation     Boston Scientific Corporation   Emily.Anderson2@bsci …

… the end of 2023. "Investors are bracing for significant macroeconomic … . (WAB) $163.38 10.04% Boston Scientific Corp. (BSX) $72.89 5 …